NCT01229111 Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers Status TERMINATED Phase PHASE2
NCT01212822 Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer Status COMPLETED Phase PHASE2
NCT01211210 Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT01206465 Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors Status COMPLETED Phase PHASE1
NCT01205711 Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01205022 Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT01198548 High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT01197664 Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery Status TERMINATED Phase PHASE1
NCT01167725 Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer Status TERMINATED Phase PHASE3
NCT01164215 Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy Status COMPLETED Phase PHASE1
NCT01154920 Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01142414 Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence Status WITHDRAWN Phase PHASE3
NCT01123473 Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer Status TERMINATED Phase PHASE2
NCT01093235 Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer Status UNKNOWN Phase PHASE3
NCT01068327 Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT01041404 ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer Status COMPLETED Phase PHASE3
NCT01031030 Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009) Status UNKNOWN Phase PHASE3
NCT01013805 Preoperative Radiotherapy and Chemotherapy in Patients With Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT01013649 Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Status COMPLETED Phase PHASE3